Skip to main content
SpringerLink
Log in

Rare Malignant Liver Tumors

  • Chapter
  • First Online:
Contrast-Enhanced Ultrasound Imaging of Hepatic Neoplasms

  • 427 Accesses

Abstract

Hypo-enhancement of solid hepatic tumors in the portal venous and late phases is the most important contrast-enhanced ultrasound (CEUS) feature for detecting malignant hepatic tumors, and contrast-enhanced ultrasound can significantly improve the detection of malignant liver tumors. This chapter will introduce conventional ultrasound and CEUS features of rare malignant liver tumors, including lymphoma, combined hepatocellular, and cholangiocarcinoma, fibrolamellar hepatocellular carcinoma, hepatic cystadenocarcinoma, neuroendocrine tumor, and hepatic epithelioid hemangioendothelioma. For some rare malignant liver tumors, surgery may not the first choice or unique therapeutic method. Further details of arterial phase enhancement patterns and the timing, degree, and patterns of washout combined with conventional ultrasound features may be helpful for diagnosis in order to guide clinical therapy selection.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

18F-FDG-EPT/CT:

Fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography

CCA:

Cholangiocarcinoma

CDFI:

Color Doppler flow imaging

CEUS:

Contrast enhanced ultrasound

cHCC-CCA:

Combined hepatocellular carcinoma and cholangiocarcinoma

CT:

Computed tomography

DLBCL:

Diffuse large B cell lymphoma

f-HCC:

Fibrolamellar hepatocellular carcinoma

FLL:

Focal liver lesion

HAS:

Hepatic angiosarcoma

HBCAC:

Hepatic biliary cystadenocarcinoma

HBCT:

Hepatic biliary cystic tumor

HCC:

Hepatocellular carcinoma

HEHE:

Hepatic epithelioid hemangioendothelioma

HL:

Hodgkin lymphoma

HNEN:

Hepatic neuroendocrine neoplasm

ICC:

Intrahepatic cholangiocarcinoma

MHNEN:

Metastatic hepatic neuroendocrine neoplasm

MRI:

Magnetic resonance image

NEN:

Neuroendocrine neoplasm

NHL:

Non-Hodgkin lymphoma

PHL:

Primary hepatic lymphoma

PHNEN:

Primary hepatic neuroendocrine neoplasm

US:

Ultrasound

References

  1. Mahajan S, Kalra S, Chawla M, Dougall P. Detection of diffuse infiltrative primary hepatic lymphoma on FDG PET-CT: hallmarks of hepatic superscan. World J Nucl Med. 2016;15:142–4.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Mastoraki A, Stefanou MI, Chatzoglou E, Danias N, Kyriazi M, Arkadopoulos N, Smyrniotis V. Primary hepatic lymphoma: dilemmas in diagnostic approach and therapeutic management. Indian J Hematol Blood Transfus. 2014;30:150–4.

    Article  PubMed  Google Scholar 

  3. Tomasian A, Sandrasegaran K, Elsayes KM, Shanbhogue A, Shaaban A, Menias CO. Hematologic malignancies of the liver: spectrum of disease. Radiographics. 2015;35:71–86.

    Article  PubMed  Google Scholar 

  4. Choi WT, Gill RM. Hepatic lymphoma diagnosis. Surg Pathol Clin. 2018;11:389–402.

    Article  PubMed  Google Scholar 

  5. Abe H, Kamimura K, Kawai H, Kamimura H, Domori K, Kobayashi Y, Nomoto M, et al. Diagnostic imaging of hepatic lymphoma. Clin Res Hepatol Gastroenterol. 2015;39:435–42.

    Article  PubMed  Google Scholar 

  6. Dong Y, Teufel A, Trojan J, Berzigotti A, Cui XW, Dietrich CF. Contrast enhanced ultrasound in mixed hepatocellular cholangiocarcinoma: case series and review of the literature. Dig Liver Dis. 2018;50:401–7.

    Article  PubMed  Google Scholar 

  7. Choi BI, Han JK, Kim YI, Kim HC, Park JH, Kim C-W, Han MC. Combined hepatocellular and cholangiocarcinoma of the liver: sonography, CT, angiography, and iodized oil CT with pathologic correlation. Abdom Radiol (NY). 1994;19:43–6.

    CAS  Google Scholar 

  8. Huang XW, Huang Y, Chen LD, Wang Z, Yang Z, Liu JY, Xie XY, et al. Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma. J Med Ultrason (2001). 2018;45:231–41.

    Article  Google Scholar 

  9. Huang X, Li Y, Long L. Comparison of imaging and clinically relevant features of combined hepatocellular carcinoma and cholangiocarcinoma with hepatocellular carcinoma. Med Sci Monit. 2019;25:8595–601.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Nishie A, Yoshimitsu K, Asayama Y, Irie H, Aibe H, Tajima T, Shinozaki K, et al. Detection of combined hepatocellular and cholangiocarcinomas on enhanced CT: comparison with histologic findings. 2004.

    Google Scholar 

  11. Sheng RF, Xie YH, Ji Y, Chen CZ, Yang L, Jin KP, Zeng MS. MR comparative study of combined hepatocellular-cholangiocarcinoma in normal, fibrotic, and cirrhotic livers. Abdom Radiol (NY). 2016;41:2102–14.

    Article  Google Scholar 

  12. Sammon J, Fischer S, Menezes R, Hosseini-Nik H, Lewis S, Taouli B, Jhaveri K. MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma. Cancer Imaging. 2018;18:8.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Sanada Y, Shiozaki S, Aoki H, Takakura N, Yoshida K, Yamaguchi Y. A clinical study of 11 cases of combined hepatocellular-cholangiocarcinoma Assessment of enhancement patterns on dynamics computed tomography before resection. Hepatol Res. 2005;32:185–95.

    Article  PubMed  Google Scholar 

  14. Nagaoka S, Itano S, Ishibashi M, Torimura T, Baba K, Akiyoshi J, Kurogi J, et al. Value of fusing PET plus CT images in hepatocellular carcinoma and combined hepatocellular and cholangiocarcinoma patients with extrahepatic metastases: preliminary findings. Liver Int. 2006;26:781–8.

    Article  PubMed  Google Scholar 

  15. Kobayashi M, Furuta K, Kitamura H, Oguchi K, Arai M, Koike S, Nakazawa K. A case of primary biliary cirrhosis that complicated with combined hepatocellular and cholangiocellular carcinoma. Clin J Gastroenterol. 2011;4:236–41.

    Article  PubMed  Google Scholar 

  16. Alen RA, Lisa JR. Combined liver cell and bileduct carcinoma. 1948.

    Google Scholar 

  17. Lee CH, Hsieh SY, Chang CJ, Lin YJ. Comparison of clinical characteristics of combined hepatocellular-cholangiocarcinoma and other primary liver cancers. J Gastroenterol Hepatol. 2013;28:122–7.

    Article  PubMed  Google Scholar 

  18. Li R, Yang D, Tang CL, Cai P, Ma KS, Ding SY, Zhang XH, et al. Combined hepatocellular carcinoma and cholangiocarcinoma (biphenotypic) tumors: clinical characteristics, imaging features of contrast-enhanced ultrasound and computed tomography. BMC Cancer. 2016;16:158.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  19. Groeschl RT, Turaga KK, Gamblin TC. Transplantation versus resection for patients with combined hepatocellular carcinoma-cholangiocarcinoma. J Surg Oncol. 2013;107:608–12.

    Article  PubMed  Google Scholar 

  20. Yin X, Zhang BH, Qiu SJ, Ren ZG, Zhou J, Chen XH, Zhou Y, et al. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis. Ann Surg Oncol. 2012;19:2869–76.

    Article  PubMed  Google Scholar 

  21. Dong Y, Wang WP, Mao F, Zhang Q, Yang D, Tannapfel A, Meloni MF, et al. Imaging features of fibrolamellar hepatocellular carcinoma with contrast-enhanced ultrasound. Ultraschall Med. 2020.

    Google Scholar 

  22. Ganeshan D, Szklaruk J, Kaseb A, Kattan A, Elsayes KM. Fibrolamellar hepatocellular carcinoma: multiphasic CT features of the primary tumor on pre-therapy CT and pattern of distant metastases. Abdom Radiol (NY). 2018;43:3340–8.

    Article  Google Scholar 

  23. Lafaro KJ, Pawlik TM. Fibrolamellar hepatocellular carcinoma: current clinical perspectives. J Hepatocell Carcinoma. 2015;2:151–7.

    PubMed  PubMed Central  Google Scholar 

  24. Chaudhari VA, Khobragade K, Bhandare M, Shrikhande SV. Management of fibrolamellar hepatocellular carcinoma. Chin Clin Oncol. 2018;7:51.

    Article  PubMed  Google Scholar 

  25. Kamaya A, Maturen KE, Tye GA, Liu YI, Parti NN, Desser TS. Hypervascular liver lesions. Semin Ultrasound CT MR. 2009;30:387–407.

    Article  PubMed  Google Scholar 

  26. Graham RP. Fibrolamellar carcinoma: what is new and why it matters. Surg Pathol Clin. 2018;11:377–87.

    Article  PubMed  Google Scholar 

  27. Chakrabarti S, Tella SH, Kommalapati A, Huffman BM, Yadav S, Riaz IB, Goyal G, et al. Clinicopathological features and outcomes of fibrolamellar hepatocellular carcinoma. J Gastrointest Oncol. 2019;10:554–61.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Lin CC, Yang HM. Fibrolamellar carcinoma: a concise review. Arch Pathol Lab Med. 2018;142:1141–5.

    Article  CAS  PubMed  Google Scholar 

  29. Kassahun WT. Contemporary management of fibrolamellar hepatocellular carcinoma: diagnosis, treatment, outcome, prognostic factors, and recent developments. World J Surg Oncol. 2016;14:151.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Ramai D, Ofosu A, Lai JK, Gao ZH, Adler DG. Fibrolamellar hepatocellular carcinoma: a population-based observational study. Dig Dis Sci. 2020.

    Google Scholar 

  31. Lewin M, Mourra N, Honigman I, Flejou JF, Parc R, Arrive L, Tubiana JM. Assessment of MRI and MRCP in diagnosis of biliary cystadenoma and cystadenocarcinoma. Eur Radiol. 2006;16:407–13.

    Article  PubMed  Google Scholar 

  32. Soares KC, Arnaoutakis DJ, Kamel I, Anders R, Adams RB, Bauer TW, Pawlik TM. Cystic neoplasms of the liver: biliary cystadenoma and cystadenocarcinoma. J Am Coll Surg. 2014;218:119–28.

    Article  PubMed  Google Scholar 

  33. Arnaoutakis DJ, Kim Y, Pulitano C, Zaydfudim V, Squires MH, Kooby D, Groeschl R, et al. Management of biliary cystic tumors: a multi-institutional analysis of a rare liver tumor. Ann Surg. 2015;261:361–7.

    Article  PubMed  Google Scholar 

  34. Dong Y, Wang WP, Mao F, Fan M, Ignee A, Serra C, Sparchez Z, et al. Contrast enhanced ultrasound features of hepatic cystadenoma and hepatic cystadenocarcinoma. Scand J Gastroenterol. 2017;52:365–72.

    Article  PubMed  Google Scholar 

  35. Xu HX, Lu MD, Liu LN, Zhang YF, Guo LH, Liu C, Wang S. Imaging features of intrahepatic biliary cystadenoma and cystadenocarcinoma on B-mode and contrast-enhanced ultrasound. Ultraschall Med. 2012;33:E241–9.

    Article  PubMed  Google Scholar 

  36. Grozinsky-Glasberg S, Kaltsas G, Kaltsatou M, Lev-Cohain N, Klimov A, Vergadis V, Uri I, et al. Hepatic intra-arterial therapies in metastatic neuroendocrine tumors: lessons from clinical practice. Endocrine. 2018;60:499–509.

    Article  CAS  PubMed  Google Scholar 

  37. Jia C, Zhang Y, Xu J, Sun K. Experience in primary hepatic neuroendocrine tumor. Turk J Gastroenterol. 2012;23:546–51.

    Article  PubMed  Google Scholar 

  38. Braden B, Jenssen C, D’Onofrio M, Hocke M, Will U, Moller K, Ignee A, et al. B-mode and contrast-enhancement characteristics of small nonincidental neuroendocrine pancreatic tumors. Endosc Ultrasound. 2017;6:49–54.

    PubMed  PubMed Central  Google Scholar 

  39. Li R, Tang CL, Yang D, Zhang XH, Cai P, Ma KS, Guo DY, et al. Primary hepatic neuroendocrine tumors: clinical characteristics and imaging features on contrast-enhanced ultrasound and computed tomography. Abdom Radiol (NY). 2016;41:1767–75.

    Article  Google Scholar 

  40. Wang LX, Liu K, Lin GW, Jiang T. Primary hepatic neuroendocrine tumors: comparing CT and MRI features with pathology. Cancer Imaging. 2015;15:13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Ronot M, Cuccioli F, Dioguardi Burgio M, Vullierme MP, Hentic O, Ruszniewski P, d’Assignies G, et al. Neuroendocrine liver metastases: vascular patterns on triple-phase MDCT are indicative of primary tumour location. Eur J Radiol. 2017;89:156–62.

    Article  PubMed  Google Scholar 

  42. Sommer WH, Zech CJ, Bamberg F, Auernhammer CJ, Helck A, Paprottka PM, Notohamiprodjo M, et al. Fluid-fluid level in hepatic metastases: a characteristic sign of metastases of neuroendocrine origin. Eur J Radiol. 2012;81:2127–32.

    Article  PubMed  Google Scholar 

  43. Schillaci O, Spanu A, Scopinaro F, Falchi A, Danieli R, Marongiu P, Pisu N, et al. Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors. J Nucl Med. 2003;44:359–68.

    CAS  PubMed  Google Scholar 

  44. Burke AP, Thomas RM, Elsayed AM, Sobin LH. Carcinoids of the jejunum and ileum: an immunohistochemical and clinicopathologic study of 167 cases. Cancer. 1997;79:1086–93.

    Article  CAS  PubMed  Google Scholar 

  45. Shinkawa H, Takatsuka S, Kaizaki R, Fujiwara Y, Kurai O, Yamazaki O. Postoperative outcomes of primary hepatic neuroendocrine carcinomas: review article. Osaka City Med J. 2013;59:105–13.

    PubMed  Google Scholar 

  46. Dong Y, Wang WP, Cantisani V, D’Onofrio M, Ignee A, Mulazzani L, Saftoiu A, et al. Contrast-enhanced ultrasound of histologically proven hepatic epithelioid hemangioendothelioma. World J Gastroenterol. 2016;22:4741–9.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Schweitzer N, Soudah B, Gebel M, Manns MP, Boozari B. Gray scale and contrast-enhanced ultrasound imaging of malignant liver tumors of vascular origin. United European Gastroenterol J. 2015;3:63–71.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Klinger C, Stuckmann G, Dietrich CF, Berzigotti A, Horger MS, Debove I, Gilot BJ, et al. Contrast-enhanced imaging in hepatic epithelioid hemangioendothelioma: retrospective study of 10 patients. Z Gastroenterol. 2019;57:753–66.

    Article  PubMed  Google Scholar 

  49. Lin J, Ji Y. CT and MRI diagnosis of hepatic epithelioid hemangioendothelioma. Hepatobiliary Pancreat Dis Int. 2010;9:154–8.

    PubMed  Google Scholar 

  50. Bruegel M, Muenzel D, Waldt S, Specht K, Rummeny EJ. Hepatic epithelioid hemangioendothelioma: findings at CT and MRI including preliminary observations at diffusion-weighted echo-planar imaging. Abdom Imaging. 2011;36:415–24.

    Article  PubMed  Google Scholar 

  51. Lyburn ID, Torreggiani WC, Harris AC, Zwirewich CV, Buckley AR, Davis JE, Chung SW, et al. Hepatic epithelioid hemangioendothelioma: sonographic, CT, and MR imaging appearances. AJR Am J Roentgenol. 2003;180:1359–64.

    Article  PubMed  Google Scholar 

  52. Gan LU, Chang R, Jin H, Yang LI. Typical CT and MRI signs of hepatic epithelioid hemangioendothelioma. Oncol Lett. 2016;11:1699–706.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Dong A, Dong H, Wang Y, Gong J, Lu J, Zuo C. MRI and FDG PET/CT findings of hepatic epithelioid hemangioendothelioma. Clin Nucl Med. 2013;38:e66–73.

    Article  PubMed  Google Scholar 

  54. Dietze O, Davies SE, Williams R, Portmann B. Malignant epithelioid haemangioendothelioma of the liver: a clinicopathological and histochemical study of 12 cases. Histopathology. 1989;15:225–37.

    Article  CAS  PubMed  Google Scholar 

  55. Dong K, Wang XX, Feng JL, Liu H, Zu KJ, Chang J, Lv FD. Pathological characteristics of liver biopsies in eight patients with hepatic epithelioid hemangioendothelioma. Int J Clin Exp Pathol. 2015;8:11015–23.

    PubMed  PubMed Central  Google Scholar 

  56. Wang LR, Zhou JM, Zhao YM, He HW, Chai ZT, Wang M, Ji Y, et al. Clinical experience with primary hepatic epithelioid hemangioendothelioma: retrospective study of 33 patients. World J Surg. 2012;36:2677–83.

    Article  PubMed  Google Scholar 

  57. Gurung S, Fu H, Zhang WW, Gu YH. Hepatic epithelioid hemangioendothelioma metastasized to the peritoneum, omentum and mesentery: a case report. Int J Clin Exp Pathol. 2015;8:5883–9.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai, China

    Qing Lu, Pei-Li Fan, Yi Dong, Jia-Ying Cao & Wen-Ping Wang

Authors
  1. Qing Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pei-Li Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yi Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jia-Ying Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Wen-Ping Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai, China

    Wen-Ping Wang

  2. Department of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai, China

    Yi Dong

  3. Allgemeine Innere Medizin, Kliniken Hirslanden Beau Site & Salem und Permanence Bern, Bern, Switzerland

    Christoph F. Dietrich

  4. Institute of Diagnostic Radiology, Interdisciplinary Ultrasound Department, University Hospital Regensburg, Regensburg, Germany

    Ernst Michael Jung

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Lu, Q., Fan, PL., Dong, Y., Cao, JY., Wang, WP. (2021). Rare Malignant Liver Tumors. In: Wang, WP., Dong, Y., Dietrich, C.F., Jung, E.M. (eds) Contrast-Enhanced Ultrasound Imaging of Hepatic Neoplasms. Springer, Singapore. https://doi.org/10.1007/978-981-16-1761-4_6

Download citation

  • DOI: https://doi.org/10.1007/978-981-16-1761-4_6

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-16-1760-7

  • Online ISBN: 978-981-16-1761-4

  • eBook Packages: EngineeringEngineering (R0)

Publish with us

Policies and ethics

Search

Navigation